Statements Author contributions Q-XL and J-DX wrote the manuscript
For example, Lemme GLP-1 Dailys website states that the product can promote your bodys GLP-1 production, reduce hunger and cravings, and support fat reduction with three clinically studied ingredients. However, their website points to studies in which the ingredients were investigated separately, in less than 200 participants
Nutritional modulation of endogenous glucagon-like peptide-1 secretion: a review
The committee concluded that the current evidence called for further action, including updated consumer and clinical safety warnings
However, these results must be contextualised carefully: Phase 2 trials are not powered to detect cardiovascular outcomes such as myocardial infarction, stroke, or cardiovascular mortality No dedicated cardiovascular outcome trial (CVOT) data exist for retatrutide such trials are required before definitive conclusions about cardiovascular benefit or risk can be drawn
Lastly, semaglutide GLP-1 has been shown to help to reduce body weight and blood pressure, which is important for those with type 2 diabetes are may be overweight or obese
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
